Novartis has forged an alliance with a Saudi Arabian manufacturer to help it expand its vaccines business in the Middle East and North African (MENA) region and neighbouring countries.

The Arab Company for Pharmaceutical Products (Arabio) is constructing a manufacturing facility in Makkah Almokarramah, with technical assistance from Novartis’ Vaccines and Diagnostics divisions, which should start operating in early 2011.